Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
Adult epilepsy market to reach $17.bn across 7MM by 2035
The adult epilepsy market across the 7MM is poised to grow at a CAGR of 4.4% from $11.4bn in 2025 to $17.8bn in 2035.
Read Full Article
Pharma Tech
Sanofi abandons eczema drug approval efforts in another blow to OX40 class
Sanofi is ceasing development of amlitelimab due to concerns around the drug's differential value from other eczema treatment offerings.
Read Full Article
Pharma Tech
BeOne to invest $300m in US manufacturing facility expansion
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.
Read Full Article
Pharma Tech
FDA grants fast track designation for Lundbeck’s Lu AH69593
Lundbeck has secured fast track designation from the US FDA for its investigational treatment, Lu AH69593, to treat narcolepsy.
Read Full Article
Express Pharma
FDD Conclave 2026: Charting the future of formulation science and drug delivery
The pharma industry is entering an era where scientific innovation must move faster, scale smarter and remain affordable. Against this backdrop, Express Pharma’s FDD Con clave 2026 brought together formulation […] The post FDD Conclave 2026: Charting the future of formulation science and drug delivery appeared first on Express Pharma.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
Pharma Tech
Jul 24, 2026, 2:45 PM
Adult epilepsy market to reach $17.bn across 7MM by 2035
The adult epilepsy market across the 7MM is poised to grow at a CAGR of 4.4% from $11.4bn in 2025 to $17.8bn in 2035.
Pharma Tech
Jul 24, 2026, 1:20 PM
Sanofi abandons eczema drug approval efforts in another blow to OX40 class
Sanofi is ceasing development of amlitelimab due to concerns around the drug's differential value from other eczema treatment offerings.
PharmaShots
Jul 24, 2026, 12:30 PM
Accord BioPharma Reports Commercial Availability of Osvyrti and Jubereq (Biosimilars, Prolia & Xgeva) in the US
Shots: Ref: PRnewswire | Image: Accord BioPharma | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Accord BioPharma Reports Commercial Availability of Osvyrti and Jubereq (Biosimilars, Prolia & Xgeva) in the US appeared first on PharmaShots.
ET Pharma
Jul 24, 2026, 11:44 AM
Novo Nordisk seeks preliminary injunction against Lilly weight-loss ads
Novo claimed Lilly compared the highest approved doses of Zepbound and Mounjaro with lower doses of Novo's Wegovy and Ozempic while omitting newer, higher-dose versions of Novo's medicines that it says deliver greater weight loss.
PharmaShots
Jul 24, 2026, 11:30 AM
Lundbeck Secures the US FDA Fast Track designation for Lu AH69593 to Treat Narcolepsy
Shots: Ref: PRnewswire | Image: Lundbeck | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Lundbeck Secures the US FDA Fast Track designation for Lu AH69593 to Treat Narcolepsy appeared first on PharmaShots.
ET Pharma
Jul 24, 2026, 11:26 AM
Merck licenses experimental HIV pill to generic makers in 129 countries
The drug, alimatravir, is currently in late-stage development. The agreements are with three sub-Saharan Africa manufacturers - Aspen Pharmacare Holdings, Quality Chemical Industries and UCL - and four Indian companies, which are Aurobindo, Cipla, Emcure and Viatris.
News
Latest industry coverage
Google News
Jul 24, 2026, 7:31 PM
Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion? - simplywall.st
Is Merck (MRK) A Bargain After FDA Approval For LIPFENDRA And HIV PrEP Expansion? simplywall.st
Google News
Jul 24, 2026, 7:29 PM
Four pharma firms, owners booked after 24,000 ointment tubes found untraceable in records - The Times of India
Four pharma firms, owners booked after 24,000 ointment tubes found untraceable in records The Times of India
Google News
Jul 24, 2026, 7:04 PM
Kolon TissueGene braces for $100 mn redemption calls on convertible bonds - KED Global
Kolon TissueGene braces for $100 mn redemption calls on convertible bonds KED Global
Google News
Jul 24, 2026, 6:00 PM
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback - Fierce Pharma
Peptide adcomm Day 2: Emideltide voted down in panel's 1st pushback Fierce Pharma
Google News
Jul 24, 2026, 5:40 PM
The Scientist With 1,000 Patents Fueling a Drug Powerhouse - WSJ
The Scientist With 1,000 Patents Fueling a Drug Powerhouse WSJ
Google News
Jul 24, 2026, 5:27 PM
Biotech companies are being reshaped by AI - SiliconANGLE
Biotech companies are being reshaped by AI SiliconANGLE
Google News
Jul 24, 2026, 5:20 PM
FDA Votes to Reduce Restrictions on Four Peptides | PharmExec - Pharmaceutical Executive
FDA Votes to Reduce Restrictions on Four Peptides | PharmExec Pharmaceutical Executive
Google News
Jul 24, 2026, 5:17 PM
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos - Reuters
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos Reuters
Google News
Jul 24, 2026, 4:49 PM
Aurobindo Pharma Enters Non-Exclusive License Agreement With MSD - Sahi
Aurobindo Pharma Enters Non-Exclusive License Agreement With MSD Sahi
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer